Comment · Thu, September 18, 2014 · Ceretropic
Creating a nootropic market... Crowdfunding, synthesis, and procurement of novel compounds! Input needed.
Original post in this thread
redan-yadayada · 6 points
I don't mean to brag; but, a lot of the novel nootropics our there today and soon to be resulted from a personal effect mostly pushed forward from my efforts. You can look at my topic history at Longecity in such compounds such as;
IDRA-21
ISRIB (TBA)
(-)-BPAP
D-deprenyl (TBA, soon)
Pitolisant
7,8-Dihydroxyflavone
GTS-21 (TBA, soon)
Neuropeptide S
F2MPA (TBA)
NRX-1074 (yes, we found the structure, TBA)
Oh, DIHEXA (possibly) and one other really promising compound that I still can't mention; but, will definitely be a great nootropic...
But, the above self tooting is besides the point... With the point, being that without your interest this would never have been possible. As, it stands now the nootropics market is composed a a few entities, Ceretropic, Newmind, THT, NootropicsDepot, and TeamTLR. IMO, a consumer driven nootropics market will always be more efficient and attract much more interest than a top down type of market that we have now. It's mostly a hybrid at the moment; but, the closer to a consumer driven market, the better, since that will allow better nootropics to be made and a more educated public.
So, until now I've relied on myself to get interestin…
What they were answering
redan-yadayada · 1 points
Is NRX-1074, compound B in the patent paper you were looking at? Just confirming if we have the same results.
As for the nootropic market, it's mostly about spreading out the risk as much as possible, and the method mentioned above is what seems to be what is most logical to me. Anyway, as it stands now things aren't done in a very democratic manner. Most compounds are synthesized from personal research into some items.
At least at this moment I think novel antidepressant compounds are the best sellers. There seems to be a lot of unrealized demand for them and that's why I'm pushing hard to get NRX-1074. PM me if it's not compound B from the patent paper. I'd love to synthesize it regardless... Thanks.
u/MisterYouAreSoDumb · Ceretropic
No, the papers we have list them by number. There are many of them. What paper are you looking at?
I think spreading out the risk is a good idea. However, I do not think it is going to be possible from a consumer level. If you can organize a way to do it, that would be cool. But I do not see enough consumers willing to participate in a risky buy like that. Perhaps if the market grows a bit.